Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1979 6
1980 23
1981 8
1982 11
1983 48
1984 26
1985 52
1986 38
1987 53
1988 37
1989 38
1990 39
1991 21
1992 16
1993 17
1994 11
1995 15
1996 9
1997 12
1998 17
1999 9
2000 6
2001 9
2002 9
2003 6
2004 2
2005 1
2006 2
2007 2
2008 1
2009 1
2010 1
2011 3
2013 4
2014 3
2016 1
2018 2
2019 1
2020 10
2021 6
2022 6
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

585 results

Results by year

Filters applied: . Clear all
Page 1
Almitrine bismesylate.
Smith PD, Gotz VP, Ryerson GG. Smith PD, et al. Drug Intell Clin Pharm. 1987 May;21(5):417-21. doi: 10.1177/106002808702100503. Drug Intell Clin Pharm. 1987. PMID: 3556128 Review.
Almitrine bismesylate is a pharmacologically unique respiratory stimulant. ...Additional research is needed to further define the role of almitrine in the relief of hypoxemia....
Almitrine bismesylate is a pharmacologically unique respiratory stimulant. ...Additional research is needed to further define the rol …
Almitrine-Raubasine combination for dementia.
Yang W, Liu M, Teng J, Hao Z, Wu B, Wu T, Liu GJ. Yang W, et al. Cochrane Database Syst Rev. 2011 Mar 16;(3):CD008068. doi: 10.1002/14651858.CD008068.pub2. Cochrane Database Syst Rev. 2011. PMID: 21412915 Review.
BACKGROUND: Almitrine-raubasine combination (brand name Duxil), has been considered as an alternative treatment for dementia. ...
BACKGROUND: Almitrine-raubasine combination (brand name Duxil), has been considered as an alternative treatment for dementia. ...
Almitrine bismesylate.
Tweney J, Howard P. Tweney J, et al. Z Erkr Atmungsorgane. 1987;168(3):197-215. Z Erkr Atmungsorgane. 1987. PMID: 2890242 Review.
There is a place in therapy for an orally active respiratory stimulant. Almitrine bismesylate is a respiratory agonist which: 1. Effectively increases PaO2 in a unique way, principally by stimulation of the peripheral chemoreceptors. 2. ...Whether this is de novo, or aggra …
There is a place in therapy for an orally active respiratory stimulant. Almitrine bismesylate is a respiratory agonist which: 1. Effe …
Hypoxia, almitrine, and peripheral neuropathy.
Howard P. Howard P. Thorax. 1989 Apr;44(4):247-50. doi: 10.1136/thx.44.4.247. Thorax. 1989. PMID: 2548298 Free PMC article. Review. No abstract available.
Clinical efficacy of almitrine-raubasine. An overview.
Allain H, Bentué-Ferrer D. Allain H, et al. Eur Neurol. 1998;39 Suppl 1:39-44. doi: 10.1159/000052069. Eur Neurol. 1998. PMID: 9516074 Review.
Different pharmacological properties of almitrine-raubasine show that this combination may be a good therapy for the treatment of age-related cerebral disorders and functional rehabilitation after stroke. ...The second is a controlled multicenter study of 155 outpatients ( …
Different pharmacological properties of almitrine-raubasine show that this combination may be a good therapy for the treatment of age …
Almitrine Infusion in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Acute Respiratory Distress Syndrome: A Single-Center Observational Study.
Caplan M, Goutay J, Bignon A, Jaillette E, Favory R, Mathieu D, Parmentier-Decrucq E, Poissy J, Duburcq T; Lille Intensive Care COVID-19 Group. Caplan M, et al. Crit Care Med. 2021 Feb 1;49(2):e191-e198. doi: 10.1097/CCM.0000000000004711. Crit Care Med. 2021. PMID: 33093279 Clinical Trial.
Comparative blood gases were done before starting almitrine trial and immediately after the end of the infusion. A positive response to almitrine was defined by an increase of Pao2/Fio2 ratio greater than or equal to 20% at the end of the infusion. ...Thirty-two pat …
Comparative blood gases were done before starting almitrine trial and immediately after the end of the infusion. A positive response …
Use of Almitrine and Inhaled Nitric Oxide in ARDS Due to COVID-19.
Laghlam D, Rahoual G, Malvy J, Estagnasié P, Brusset A, Squara P. Laghlam D, et al. Front Med (Lausanne). 2021 Jul 1;8:655763. doi: 10.3389/fmed.2021.655763. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34277653 Free PMC article.
Baseline PaO(2)/FiO(2) was 146 48 mmHg. When iNO was combined with almitrine, PaO(2)/FiO(2) rose to 255 90 mmHg (+80 49%, p = 0.005), also after almitrine alone: 238 98 mmHg (+67 75%, p = 0.02), but not after iNO alone: 185 73 mmHg (+30 5%, p = 0.49). No adverse eve …
Baseline PaO(2)/FiO(2) was 146 48 mmHg. When iNO was combined with almitrine, PaO(2)/FiO(2) rose to 255 90 mmHg (+80 49%, p = 0.005), …
585 results

Searches related to "almitrine"